BIODESIX BDSX 深 沪
交易中 09-20 14:44:46 美东时间
1.795
+0.015
+0.84%
华盛通- 最 高1.845
- 今 开1.79
- 成交量 13.62万股
- 最 低 1.78
- 昨 收 1.78
- 总市值 1.74亿
- 52周最高 2.21
- 市盈率 静 --
- 换手率 0.14%
- 52周最低 1.15
- 委 比 -11.28%
- 总股本 9694.21万
- 历史最高 31.99
- 量 比 1.98
- 振 幅 3.65%
- 历史最低 0.955
- 每 手 1
- 风险率 0.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Scotiabank Initiates Coverage On Biodesix with Sector Outperform Rating, Announces Price Target of $3
Scotiabank analyst Sung Ji Nam initiates coverage on Biodesix (NASDAQ:BDSX) with a Sector Outperform rating and announces Price Target of $3.
09-17 01:56
Biodesix Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
09-17 01:54
Biodesix Releases Updated Corporate Presentation Information
The latest update is out from Biodesix (BDSX). Biodesix has updated their corpo...
08-15 18:47
快讯 | Biodesix公司-将2024年全年营业收入指导提高至7,000万-7,200万美元，而原指导为6,500万-6,800万美元。
Biodesix Inc - Raises Full-Year 2024 Revenue Guidance to $70-72 Mln From $65-68...
08-08 04:02
快讯 | biodesix第二季度营业收入为1790万美元，相比于IBES估计的1620万美元更高。
Biodesix Q2 Revenue USD 17.9 Million Vs. IBES Estimate USD 16.2 Million
08-08 04:01
EverCommerce appoints Ryan Siurek as CFO
EverCommerce (NASDAQ:EVCM) on Tuesday announced that it has appointed Ryan Siurek as chief financial officer, effective September 6, 2024. Current CFO Marc Thompson will remain with the company throug...
08-07 05:28
Buy Rating Justified by Biodesix’s Market Leadership and Strong Growth Prospects
Daniel Brennan, an analyst from TD Cowen, has initiated a new Buy rating on Bio...
05-13 17:45
Biodesix Reaffirms 2024 Revenue Guidance $65M-$68M
Biodesix Reaffirms 2024 Revenue Guidance $65M-$68M
05-09 05:06
Biodesix Q1 2024 GAAP EPS $(0.14), Inline, Sales $14.818M Beat $14.180M Estimate
Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 41.67 percent increase over losses of $(0.24) per share from the same period last year. The
05-09 04:08
Biodesix(BDSX.US)获Lake Street首次覆盖，给予买入评级, 目标价3.00美元。
Biodesix(BDSX.US)获Lake Street首次覆盖，给予买入评级, 目标价3.00美元。
05-04 00:10
